Supplements

Therapies targeting the neuro-vascular-immune triad show promise for treating rosacea but lack large-scale randomized controlled trials.

This review summarizes rosacea treatments targeting the neuro-vascular-immune triad, including γ-aminobutyric acid derivatives, antidepressants, anti-calcitonin gene-related peptide agents, physical neuromodulation, botulinum toxin type A, and β-blockers. The authors note that while these therapies can specifically regulate different stages of the pathway, their evidence lacks large-scale randomized controlled trials and clarity regarding optimal dosing regimens and treatment durations.

Last updated: Jul 15, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad.

observational

Yang X, Yang W, Chen N, Li D, Xu Y · Frontiers in immunology (2026)

Participants: N/A
Duration: N/A
Intervention: Therapies targeting the neuro-vascular-immune triad (e.g., γ-aminobutyric acid derivatives, antidepressants, anti-calcitonin gene-related peptide agents, physical neuromodulation, botulinum toxin type A, β-blockers)
Outcome: Clinical efficacy in treating rosacea symptoms (paroxysmal flushing, persistent erythema, telangiectasia, papules, pustules, ocular symptoms)
Effect Size: N/A
Population: Patients with rosacea

Result:

PubMed: 42440475DOI: 10.3389/fimmu.2026.1876564

Mechanism Graph

Abnormal activation of the neuro-vascular-immune triad is a crucial pathological mechanism of rosacea
↓
Dysregulation within the central nervous system may exacerbate disease progression by modulating peripheral nerve activity and neuroendocrine homeostasis
↓
Therapies target different stages of this pathway
↓
Result: Potential reduction in rosacea symptoms

Limitations

  • ⚠Lack of large-scale randomized controlled trials
  • ⚠Unclear optimal dosing regimens and treatment durations

Frequently Asked Questions

What is the neuro-vascular-immune triad in rosacea?▼

It is a proposed pathological mechanism involving abnormal interactions between the nervous system, blood vessels, and immune system that contribute to rosacea symptoms.

Which therapies are reviewed for targeting this triad?▼

The review covers γ-aminobutyric acid derivatives, antidepressants, anti-calcitonin gene-related peptide agents, physical neuromodulation (transcutaneous auricular vagus nerve and repetitive transcranial magnetic stimulations), botulinum toxin type A, and β-blockers.

What are the main limitations of current evidence for these therapies?▼

The evidence lacks large-scale randomized controlled trials and clarity regarding optimal dosing regimens and treatment durations.

Does this paper focus on sleep disturbances in rosacea?▼

The abstract mentions sleep disturbances as a complication of severe rosacea, but the primary focus is on treatments targeting the neuro-vascular-immune triad, not sleep specifically.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Yang X, Yang W, Chen N, Li D, Xu Y. "Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad.." Frontiers in immunology, 2026. PMID: 42440475 DOI: 10.3389/fimmu.2026.1876564
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.